Proinflammatory cytokines such as tumor necrosis factor‐alpha (TNF‐α) and interleukin‐6 (IL‐6) are strongly associated with the progression and exacerbation of inflammatory bowel disease (IBD)108, 109; highlighting their potential as clinical biomarkers for IBD diagnosis and disease monitoring. Here, IL6 is linked to inflammatory bowel disease.